|  |



Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir ...

There are limited data on how historical nucleoside reverse transcriptase inhibitor (NRTI) resistance-associated mutations (RAMs) other than ...


View article...


Top stories of the last 30 days